Cargando…

The Genetic Complexity of Prostate Cancer

Prostate cancer (PCa) is a major concern in public health, with many genetically distinct subsets. Genomic alterations in PCa are extraordinarily complex, and both germline and somatic mutations are of great importance in the development of this tumor. The aim of this review is to provide an overvie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Compérat, Eva, Wasinger, Gabriel, Oszwald, André, Kain, Renate, Cancel-Tassin, Geraldine, Cussenot, Olivier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760266/ https://www.ncbi.nlm.nih.gov/pubmed/33255593 http://dx.doi.org/10.3390/genes11121396

Ejemplares similares

PD-L1 (SP142) testing is concordant between Benchmark Ultra and Bond-III stainers
por: Compérat, Eva, et al.
Publicado: (2021)

Pathological reporting of cystectomy lymph nodes: a retrospective analysis of experience in Paris
por: Oszwald, André, et al.
Publicado: (2021)

Region 2 of 8q24 is associated with the risk of aggressive prostate cancer in Caribbean men of African descent from Guadeloupe (French West Indies)
por: Cancel-Tassin, Geraldine, et al.
Publicado: (2015)

Assessment of Xpert Bladder Cancer Monitor test performance for the detection of recurrence during non-muscle invasive bladder cancer follow-up
por: Cancel-Tassin, G., et al.
Publicado: (2021)

Updated pathology reporting standards for bladder cancer: biopsies, transurethral resections and radical cystectomies
por: Compérat, Eva, et al.
Publicado: (2021)

Night work and prostate cancer risk: results from the EPICAP Study
por: Wendeu-Foyet, Méyomo Gaelle, et al.
Publicado: (2018)

Detection of specific chromosomal aberrations in urine using BCA-1 (oligo-CGH-array) enhances diagnostic sensitivity and predicts the aggressiveness of non-muscle-invasive bladder transitional cell carcinoma
por: Cussenot, Olivier, et al.
Publicado: (2013)

Homologous recombination deficiency (HRD) score in germline BRCA2- versus ATM-altered prostate cancer
por: Lotan, Tamara L., et al.
Publicado: (2021)

Computer-assisted evaluation enhances the quantification of interstitial fibrosis in renal implantation biopsies, measures differences between frozen and paraffin sections, and predicts delayed graft function
por: Pavlovic, Mladen, et al.
Publicado: (2022)

Interplay between Prostate Cancer and Adipose Microenvironment: A Complex and Flexible Scenario
por: Cancel, Mathilde, et al.
Publicado: (2022)

A GWAS in uveal melanoma identifies risk polymorphisms in the CLPTM1L locus
por: Mobuchon, Lenha, et al.
Publicado: (2017)

Functional characterization of 5p15.33 risk locus in uveal melanoma reveals rs452384 as a functional variant and NKX2.4 as an allele-specific interactor
por: Derrien, Anne-Céline, et al.
Publicado: (2022)

Genetic and Epigenetic Characteristics in Isolated Pancreatic Metastases of Clear-Cell Renal Cell Carcinoma
por: Sellner, Franz, et al.
Publicado: (2023)

Different Pigmentation Risk Loci for High-Risk Monosomy 3 and Low-Risk Disomy 3 Uveal Melanomas
por: Mobuchon, Lenha, et al.
Publicado: (2021)

Clinical relevance of genetic instability in prostatic cells obtained by prostatic massage in early prostate cancer
por: Thuret, R, et al.
Publicado: (2005)

Single-lesion Prostate-specific Membrane Antigen Protein Expression (PSMA) and Response to [(177)Lu]-PSMA-ligand Therapy in Patients with Castration-resistant Prostate Cancer
por: Stangl-Kremser, Judith, et al.
Publicado: (2021)

HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG)
por: Xu, Jianfeng, et al.
Publicado: (2012)

Complement-Mediated Thrombotic Microangiopathy Related to COVID-19 or SARS-CoV-2 Vaccination
por: Aigner, Christof, et al.
Publicado: (2023)

More than ancillary records: clinical implications of renal pathology examination in tumor nephrectomy specimens
por: Kläger, Johannes Philipp, et al.
Publicado: (2021)

Evaluation of APOBEC3 expression as prognostic marker in squamous cell carcinoma of the penis
por: Trimmel, Bettina, et al.
Publicado: (2022)

Y chromosome haplogroups and prostate cancer in populations of European and Ashkenazi Jewish ancestry
por: Wang, Zhaoming, et al.
Publicado: (2012)

Fine mapping the KLK3 locus on chromosome 19q13.33 associated with prostate cancer susceptibility and PSA levels
por: Parikh, Hemang, et al.
Publicado: (2011)

Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families
por: Bailey-Wilson, Joan E, et al.
Publicado: (2012)

Adaptation and validation of the memorial anxiety scale for prostate cancer (MAX-PC) in a sample of French men
por: Touzani, Rajae, et al.
Publicado: (2019)

A microdissection approach to detect molecular markers during progression of prostate cancer.
por: Berthon, P., et al.
Publicado: (1995)

Complexities of Prostate Cancer
por: Wasim, Sobia, et al.
Publicado: (2022)

Two Susceptibility Loci Identified for Prostate Cancer Aggressiveness
por: Berndt, Sonja I., et al.
Publicado: (2015)

Single Donor Infusion of S-Nitroso-Human-Serum-Albumin Attenuates Cardiac Isograft Fibrosis and Preserves Myocardial Micro-RNA-126-3p in a Murine Heterotopic Heart Transplant Model
por: Schaefer, Anne-Kristin, et al.
Publicado: (2022)

What Does COVID-19 Mean for the Pathology-Urology Interaction?
por: Compérat, Eva
Publicado: (2020)

The expression and role of tenascin C in abdominal aortic aneurysm formation and progression
por: Nagel, Felix, et al.
Publicado: (2022)

(68)Ga-PSMA-11 PET/CT in restaging castration-resistant nonmetastatic prostate cancer: detection rate, impact on patients’ disease management and adequacy of impact
por: Fourquet, Aloÿse, et al.
Publicado: (2020)

Modulating Chaperone-Mediated Autophagy and Its Clinical Applications in Cancer
por: Hubert, Virginie, et al.
Publicado: (2022)

The Clinical Genetics of Prostate Cancer
por: Kommu, Sashi, et al.
Publicado: (2004)

Genetics and biology of prostate cancer
por: Wang, Guocan, et al.
Publicado: (2018)

Renal Cell Carcinoma with Sarcomatoid Features: Finally New Therapeutic Hope?
por: Pichler, Renate, et al.
Publicado: (2019)

ASCO 2018: highlights of urothelial cancer and prostate cancer
por: Pichler, Renate, et al.
Publicado: (2018)

Rare Germline Variants in ATM Predispose to Prostate Cancer: A PRACTICAL Consortium Study
por: Karlsson, Questa, et al.
Publicado: (2021)

Genetic predisposition to prostate cancer: an update
por: Ni Raghallaigh, Holly, et al.
Publicado: (2021)

Restaging the Biochemical Recurrence of Prostate Cancer with [(68)Ga]Ga-PSMA-11 PET/CT: Diagnostic Performance and Impact on Patient Disease Management
por: Fourquet, Aloÿse, et al.
Publicado: (2021)

S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors
por: Rehman, I, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_meafo73i8j0i70rmihq403ak0h